No significant weaknesses identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| ELMDElectromed, Inc. | 239.29M | 28.69 | 33.36 | 16.97% | 12.38% | 18.32% | 4.63% | 0.00 |
| XAIRBeyond Air, Inc. | 7.02M | 0.88 | -0.06 | 219.67% | -6.32% | -280.24% | 0.82 | |
| LUNGPulmonx Corporation | 82.08M | 1.99 | -1.38 | 22.01% | -61.91% | -94.54% | 0.66 | |
| AVNSAvanos Medical, Inc. | 555.63M | 11.97 | -1.40 | 2.15% | -67% | -60.27% | 14.92% | 0.21 |
| INGNInogen, Inc. | 168.59M | 6.21 | -4.09 | 6.35% | -7.31% | -12.87% | 0.11 | |
| QIPTQuipt Home Medical Corp. | 156.3M | 3.55 | -14.79 | -0.23% | -4.11% | -10.06% | 16.21% | 0.16 |
| IINNInspira Technologies Oxy B.H.N. Ltd. | 34.51M | 0.96 | -1600 | -190.28% | 0.58 |
| Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 96.33M | 61.56M | 54.58M | 61.16M | 73.17M | 102.35M | 139.86M | 211.68M | 245.91M | 245.36M |
| Revenue Growth % | 0.8% | -0.36% | -0.11% | 0.12% | 0.2% | 0.4% | 0.37% | 0.51% | 0.16% | -0% |
| Cost of Goods Sold | 24.2M | 17.94M | 21.74M | 17.06M | 34.73M | 28.17M | 33.21M | 57.9M | 68.92M | 6.05M |
| COGS % of Revenue | 0.25% | 0.29% | 0.4% | 0.28% | 0.47% | 0.28% | 0.24% | 0.27% | 0.28% | 0.02% |
| Gross Profit | 49.07M | 43.62M | 37.75M | 44.1M | 38.45M | 74.18M | 106.65M | 153.78M | 176.99M | 239.31M |
| Gross Margin % | 0.51% | 0.71% | 0.69% | 0.72% | 0.53% | 0.72% | 0.76% | 0.73% | 0.72% | 0.98% |
| Gross Profit Growth % | 0.38% | -0.11% | -0.13% | 0.17% | -0.13% | 0.93% | 0.44% | 0.44% | 0.15% | 0.35% |
| Operating Expenses | 83.19M | 56.51M | 40.53M | 44.1M | 39.08M | 75.64M | 101.92M | 150.93M | 175.88M | 125.46M |
| OpEx % of Revenue | 0.86% | 0.92% | 0.74% | 0.72% | 0.53% | 0.74% | 0.73% | 0.71% | 0.72% | 0.51% |
| Selling, General & Admin | 61.02M | 28.77M | 29.5M | 22.46M | 25.04M | 49.76M | 53.82M | 82.37M | 94.69M | 0 |
| SG&A % of Revenue | 0.63% | 0.47% | 0.54% | 0.37% | 0.34% | 0.49% | 0.38% | 0.39% | 0.39% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 22.18M | 27.74M | 11.03M | 21.64M | 14.04M | 25.88M | 48.09M | 68.56M | 81.18M | 125.46M |
| Operating Income | -40.61M | -12.89M | -5.31M | -4.63M | -634.63K | -1.46M | 4.73M | 5.76M | 1.11M | -3.82M |
| Operating Margin % | -0.42% | -0.21% | -0.1% | -0.08% | -0.01% | -0.01% | 0.03% | 0.03% | 0% | -0.02% |
| Operating Income Growth % | -6.63% | 0.68% | 0.59% | 0.13% | 0.86% | -1.3% | 4.24% | 0.22% | -0.81% | -4.43% |
| EBITDA | -30.02M | -438K | 6.37M | 5.92M | 13.9M | 16.33M | 27.77M | 45.92M | 51.67M | -3.82M |
| EBITDA Margin % | -0.31% | -0.01% | 0.12% | 0.1% | 0.19% | 0.16% | 0.2% | 0.22% | 0.21% | -0.02% |
| EBITDA Growth % | -2.89% | 0.99% | 15.55% | -0.07% | 1.35% | 0.17% | 0.7% | 0.65% | 0.13% | -1.07% |
| D&A (Non-Cash Add-back) | 10.59M | 12.45M | 11.68M | 10.55M | 14.54M | 17.79M | 23.04M | 40.16M | 50.55M | 0 |
| EBIT | -34.96M | -20.36M | -4.97M | -4.78M | -1.74M | -7.34M | 5.01M | 4.93M | 514K | 0 |
| Net Interest Income | -847K | -1.13M | -1.48M | -3.22M | -1.86M | -1.99M | -1.92M | -7.24M | -8.55M | 0 |
| Interest Income | 281.42K | 0 | 1.55K | 25.68K | 0 | 0 | 0 | 366.31K | 791.49K | -467K |
| Interest Expense | 1.13M | 1.13M | 1.48M | 3.25M | 1.86M | 1.99M | 1.92M | 7.61M | 9.34M | 6.74M |
| Other Income/Expense | 4.8M | -8.59M | -1.13M | -4.25M | -2.94M | -7.87M | -1.8M | 0 | -7.77M | -6.52M |
| Pretax Income | -35.81M | -21.49M | -6.45M | -8.87M | -3.58M | -9.33M | 2.94M | -2.7M | -6.65M | -10.34M |
| Pretax Margin % | -0.37% | -0.35% | -0.12% | -0.15% | -0.05% | -0.09% | 0.02% | -0.01% | -0.03% | -0.04% |
| Income Tax | -8.33M | 354.69K | 100.62K | 203.2K | 128K | -3.15M | -1.9M | 85K | 109K | 241K |
| Effective Tax Rate % | 1.6% | 0.89% | -2.25% | 0.63% | 1.28% | 0.66% | 1.65% | 1.03% | 1.02% | 1.02% |
| Net Income | -57.37M | -19.15M | 14.51M | -5.58M | -4.57M | -6.17M | 4.84M | -2.78M | -6.76M | -10.58M |
| Net Margin % | -0.6% | -0.31% | 0.27% | -0.09% | -0.06% | -0.06% | 0.03% | -0.01% | -0.03% | -0.04% |
| Net Income Growth % | -2.13% | 0.67% | 1.76% | -1.38% | 0.18% | -0.35% | 1.78% | -1.58% | -1.43% | -0.56% |
| Net Income (Continuing) | -27.48M | -21.84M | -6.55M | -6.91M | -3.7M | -6.17M | 4.84M | -2.78M | -6.76M | 0 |
| Discontinued Operations | 0 | 0 | 0 | 1.33M | -869K | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.7M |
| EPS (Diluted) | -3.23 | -1.02 | 0.72 | -0.27 | -0.20 | -0.20 | 0.13 | -0.07 | -0.16 | -0.24 |
| EPS Growth % | -1.02% | 0.68% | 1.71% | -1.38% | 0.26% | 0% | 1.65% | -1.54% | -1.29% | -0.5% |
| EPS (Basic) | -3.23 | -1.02 | 0.72 | -0.27 | -0.17 | -0.20 | 0.14 | -0.07 | -0.16 | -0.24 |
| Diluted Shares Outstanding | 17.76M | 18.85M | 20.19M | 20.71M | 22.72M | 30.44M | 37.22M | 39.77M | 42.5M | 43.29M |
| Basic Shares Outstanding | 17.76M | 18.85M | 20.19M | 20.71M | 28.05M | 30.44M | 34.56M | 39.77M | 42.5M | 43.29M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 30.83M | 18.36M | 17.79M | 23.25M | 45.28M | 57.23M | 41.54M | 65.43M | 73.05M | 78.35M |
| Cash & Short-Term Investments | 5.17M | 2.73M | 3.35M | 9.71M | 29.23M | 34.61M | 8.52M | 17.21M | 16.17M | 12.92M |
| Cash Only | 5.17M | 2.73M | 3.35M | 9.71M | 29.23M | 34.61M | 8.52M | 17.21M | 16.17M | 12.92M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 18.32M | 7.67M | 9.69M | 9.36M | 9.09M | 11.94M | 16.38M | 25.98M | 29.12M | 34.7M |
| Days Sales Outstanding | 69.42 | 45.5 | 64.82 | 55.84 | 45.34 | 42.57 | 42.76 | 44.79 | 43.22 | 51.62 |
| Inventory | 6.19M | 7.89M | 4.37M | 3.58M | 6.42M | 9.25M | 15.59M | 18.41M | 20.85M | 25.64M |
| Days Inventory Outstanding | 93.4 | 160.5 | 73.3 | 76.58 | 67.43 | 119.88 | 171.27 | 116.09 | 110.43 | 1.55K |
| Other Current Assets | 0 | -601.77K | 0 | 2.74K | -183.08K | 0 | 0 | 3.83M | 926K | 5.1M |
| Total Non-Current Assets | 80.71M | 21.18M | 20.22M | 18.42M | 26.78M | 51.34M | 90.68M | 181.97M | 173.92M | 126.59M |
| Property, Plant & Equipment | 26.2M | 16.63M | 16.17M | 14.73M | 12.48M | 23.51M | 33.5M | 53.41M | 53.86M | 64.45M |
| Fixed Asset Turnover | 3.68x | 3.70x | 3.38x | 4.15x | 5.86x | 4.35x | 4.18x | 3.96x | 4.57x | 3.81x |
| Goodwill | 18.55M | 1.43M | 1.42M | 1.42M | 2.92M | 12.46M | 28.21M | 52.83M | 50.73M | 61.56M |
| Intangible Assets | 35.87M | 3.03M | 2.53M | 2.2M | 4.18M | 14.87M | 28.89M | 74.04M | 67.95M | 77.56M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 118.17K | 1.4M | 1.31M | 0 |
| Other Non-Current Assets | 96.6K | 84.64K | 89.78K | 71.01K | 7.21M | 504K | 86K | 300.76K | 337K | -76.98M |
| Total Assets | 111.54M | 102.55M | 38.01M | 41.67M | 72.06M | 108.57M | 132.21M | 247.41M | 246.86M | 204.94M |
| Asset Turnover | 0.86x | 0.60x | 1.44x | 1.47x | 1.02x | 0.94x | 1.06x | 0.86x | 1.00x | 1.20x |
| Asset Growth % | -0.3% | -0.08% | -0.63% | 0.1% | 0.73% | 0.51% | 0.22% | 0.87% | -0% | -0.17% |
| Total Current Liabilities | 14.68M | 14.16M | 14.24M | 18.02M | 24.39M | 32.74M | 41.74M | 60.57M | 60.85M | 74.71M |
| Accounts Payable | 6.92M | 6.65M | 4.87M | 6.13M | 7.43M | 9.84M | 13.84M | 24.74M | 29.31M | 0 |
| Days Payables Outstanding | 104.44 | 135.36 | 81.77 | 131.25 | 78.14 | 127.51 | 152.11 | 155.94 | 155.21 | - |
| Short-Term Debt | 973.57K | 0 | 0 | 8.18M | 4.31M | 6.99M | 12.33M | 17.47M | 16.05M | 6.9M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 502K | 443.94K | 73.53K | 1.54M | 1.81M | 0 | 0 | 4.93M | 4.58M | 63.22M |
| Current Ratio | 2.10x | 1.30x | 1.25x | 1.29x | 1.86x | 1.75x | 1.00x | 1.08x | 1.20x | 1.05x |
| Quick Ratio | 1.68x | 0.74x | 0.94x | 1.09x | 1.59x | 1.47x | 0.62x | 0.78x | 0.86x | 0.71x |
| Cash Conversion Cycle | 58.37 | 70.64 | 56.34 | 1.17 | 34.63 | 34.94 | 61.92 | 4.94 | -1.57 | - |
| Total Non-Current Liabilities | 5.64M | 9.26M | 8.85M | 15.42M | 20.06M | 17.21M | 10.93M | 75.72M | 79.21M | 96.48M |
| Long-Term Debt | 5.64M | 5.08M | 5.57M | 11.68M | 18.16M | 12.3M | 3.73M | 61.35M | 64.6M | 13.04M |
| Capital Lease Obligations | 0 | 2.95M | 3.29M | 1.04M | 3.23M | 4.78M | 7.2M | 14.03M | 13.32M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 344K | 202K | 287K |
| Other Non-Current Liabilities | 0 | 0 | 0 | 2.71M | -1.33M | 133K | 3.25M | 0 | 1.12M | 83.15M |
| Total Liabilities | 20.32M | 30.79M | 23.09M | 33.44M | 41.54M | 49.95M | 52.67M | 136.29M | 140.06M | 171.19M |
| Total Debt | 11.01M | 13.24M | 16.33M | 21.32M | 27.74M | 27.05M | 26.56M | 97.96M | 99.8M | 19.94M |
| Net Debt | 5.84M | 10.17M | 12.98M | 11.61M | -1.49M | -7.56M | 23.01M | 80.75M | 83.63M | 7.03M |
| Debt / Equity | 0.12x | 0.18x | 1.09x | 1.47x | 0.98x | 0.46x | 0.33x | 0.88x | 0.93x | 0.16x |
| Debt / EBITDA | - | - | 2.56x | 3.60x | 2.00x | 1.66x | 0.96x | 2.13x | 1.93x | - |
| Net Debt / EBITDA | - | - | 2.04x | 1.96x | -0.11x | -0.46x | 0.83x | 1.76x | 1.62x | - |
| Interest Coverage | -36.00x | -11.42x | -3.60x | -1.42x | -0.34x | -0.73x | 2.46x | 0.76x | 0.12x | -0.57x |
| Total Equity | 91.21M | 71.76M | 14.91M | 14.47M | 28.23M | 58.62M | 79.55M | 111.11M | 107.19M | 123.8M |
| Equity Growth % | -0.3% | -0.21% | -0.79% | -0.03% | 0.95% | 1.08% | 0.36% | 0.4% | -0.04% | 0.15% |
| Book Value per Share | 5.14 | 3.81 | 0.74 | 0.70 | 1.24 | 1.93 | 2.14 | 2.79 | 2.52 | 2.86 |
| Total Shareholders' Equity | 91.21M | 71.76M | 14.91M | 17.25M | 28.23M | 58.62M | 79.55M | 111.11M | 107.19M | 112.1M |
| Common Stock | 146.84M | 155.95M | 150.12M | 151.96M | 171.41M | 202.83M | 214.25M | 247.53M | 0 | 0 |
| Retained Earnings | -81.96M | -106.01M | -159.48M | -215.34M | -159.69M | -165.86M | -161.02M | -163.81M | -170.57M | -181.27M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 12.14M | 8M | 9.54M | 9.82M | 9.91M | 656.03K | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.7M |
| Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -4.46M | -6.07M | 10.64M | 8.39M | 9.89M | 17.76M | 26.34M | 36.98M | 35.38M | 37.69M |
| Operating CF Margin % | -0.05% | -0.1% | 0.2% | 0.14% | 0.14% | 0.17% | 0.19% | 0.17% | 0.14% | 0.15% |
| Operating CF Growth % | -0.87% | -0.36% | 2.75% | -0.21% | 0.18% | 0.8% | 0.48% | 0.4% | -0.04% | 0.07% |
| Net Income | -57.37M | -19.15M | -5.39M | -5.58M | -3.79M | -6.17M | 6.68M | -3.78M | -6.76M | -10.7M |
| Depreciation & Amortization | 22.18M | 12.45M | 12.02M | 10.55M | 10.98M | 17.73M | 23.04M | 41.23M | 50.55M | 51.92M |
| Stock-Based Compensation | 7.92M | -1.21M | 1.29M | 1.56M | 128.44K | 4.95M | 7.59M | 5.28M | 2.48M | 4.04M |
| Deferred Taxes | -8.15M | 0 | 4.06M | 4.3M | 4.96M | -3.8M | 0 | -548K | 342K | 85K |
| Other Non-Cash Items | 55.19M | 6.04M | 3.04M | 1.39M | 1.12M | 13.9M | -11.72M | -3.19M | -3.54M | -7.64M |
| Working Capital Changes | -24.24M | -4.2M | -4.38M | -3.82M | -3.5M | -8.85M | 758K | -2.01M | -7.7M | 0 |
| Change in Receivables | -19.74M | -4.21M | -7M | -5.16M | -3.86M | -8.82M | -201K | -3.06M | -3.29M | 2.58M |
| Change in Inventory | 176.46K | -3.98M | 3.69M | 637.56K | -1.33M | -44K | -2.42M | -60K | -3.42M | -2.42M |
| Change in Payables | -3.75M | 0 | -4.12M | 0 | 1.66M | 518K | 3.35M | 3.12M | 3.13M | -3.41M |
| Cash from Investing | -22.93M | 9.3M | -723.68K | 1.77M | -5.93M | -17.84M | -42.49M | -82.83M | -10.31M | -32.95M |
| Capital Expenditures | -2.94M | -2.44M | -530.18K | -1.36M | -69.02K | -5.05M | -9.16M | -6.85M | -10.31M | -12.35M |
| CapEx % of Revenue | 0.03% | 0.04% | 0.01% | 0.02% | 0% | 0.05% | 0.07% | 0.03% | 0.04% | 0.05% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 11.87M | 229.1K | 161.66K | 190.79K | 98K | 193K | 65K | 210K | 1.23M |
| Cash from Financing | -6.54M | -6.53M | -10.51M | -5.03M | 10.48M | 4.84M | -9.85M | 54.43M | -26.15M | -7.76M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | -3.38M | -4.75M | 123.7K | 756.65K | -1.75M | -1.21M | -5.3M | -653.79K | -1.01M | -7.76M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -7.4M | -7.33M | 10.11M | 7.03M | 9.82M | 13.65M | 17.18M | 30.13M | 25.07M | 25.34M |
| FCF Margin % | -0.08% | -0.12% | 0.19% | 0.11% | 0.13% | 0.13% | 0.12% | 0.14% | 0.1% | 0.1% |
| FCF Growth % | 0.07% | 0.01% | 2.38% | -0.31% | 0.4% | 0.39% | 0.26% | 0.75% | -0.17% | 0.01% |
| FCF per Share | -0.42 | -0.39 | 0.50 | 0.34 | 0.43 | 0.45 | 0.46 | 0.76 | 0.59 | 0.59 |
| FCF Conversion (FCF/Net Income) | 0.08x | 0.32x | 0.73x | -1.50x | -2.16x | -2.88x | 5.44x | -13.28x | -5.23x | -3.56x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.03M | 6.83M | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 680K | 1.25M | 0 |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -51.66% | -23.5% | 33.48% | -37.98% | -21.41% | -14.22% | 7% | -2.92% | -6.2% | -9.16% |
| Return on Invested Capital (ROIC) | -30.74% | -10.78% | -7.23% | -12.86% | -1.8% | -2.81% | 4.77% | 2.98% | 0.44% | -1.78% |
| Gross Margin | 50.94% | 70.86% | 69.17% | 72.11% | 52.54% | 72.48% | 76.25% | 72.65% | 71.97% | 97.53% |
| Net Margin | -59.56% | -31.11% | 26.59% | -9.12% | -6.25% | -6.03% | 3.46% | -1.32% | -2.75% | -4.31% |
| Debt / Equity | 0.12x | 0.18x | 1.09x | 1.47x | 0.98x | 0.46x | 0.33x | 0.88x | 0.93x | 0.16x |
| Interest Coverage | -36.00x | -11.42x | -3.60x | -1.42x | -0.34x | -0.73x | 2.46x | 0.76x | 0.12x | -0.57x |
| FCF Conversion | 0.08x | 0.32x | 0.73x | -1.50x | -2.16x | -2.88x | 5.44x | -13.28x | -5.23x | -3.56x |
| Revenue Growth | 80.35% | -36.09% | -11.35% | 12.07% | 19.63% | 39.88% | 36.65% | 51.35% | 16.17% | -0.23% |
Quipt Home Medical Corp. (QIPT) reported $250.8M in revenue for fiscal year 2025. This represents a 6228% increase from $4.0M in 2012.
Quipt Home Medical Corp. (QIPT) saw revenue decline by 0.2% over the past year.
Quipt Home Medical Corp. (QIPT) reported a net loss of $10.3M for fiscal year 2025.
Quipt Home Medical Corp. (QIPT) has a return on equity (ROE) of -9.2%. Negative ROE indicates the company is unprofitable.
Quipt Home Medical Corp. (QIPT) generated $20.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.